Drug developers take fresh aim at 'guided-missile' cancer drugs

Dozens of drugmakers are conducting human trials for a record 89 therapies that pair antibodies with toxic agents to fight cancer, evidence of renewed confidence in an approach that has long fallen short of its promise, an analysis compiled for Reuters shows.

from Reuters: Health News https://ift.tt/35nZuS1